INTRODUCTION
============

Obesity is reported to be a major risk factor of functional and physical impairments in the elderly.[@b1-jomes-26-036] In addition, decreased resting metabolic rate accompanying aging is known as a key driver of gradual skeletal muscle mass loss and fat gain.[@b2-jomes-26-036]

Sarcopenia is a progressive muscle mass loss associated with aging. In particular, decreased skeletal muscle mass is a prominent change that accompanies aging.[@b3-jomes-26-036] In addition to reduced muscle mass, sarcopenia is characterized by decreased muscle strength and increased fat mass[@b4-jomes-26-036], which can lead to impaired mobility, increased risk of falling, impaired daily function, decreased independence, and shortened life expectancy.[@b5-jomes-26-036]

Sarcopenic obesity is sarcopenia accompanied with obesity in the elderly population. Sarcopenic obesity can increase the risk of functional impairment, reduce quality of life, and increase morbidity in the elderly owing to the interaction of the two underlying conditions.[@b6-jomes-26-036] The prevalence of sarcopenia obesity increases among the aged. Sarcopenia obesity increases cardiovascular disorders and insulin resistance, and is highly associated with metabolic syndromes.[@b7-jomes-26-036],[@b8-jomes-26-036]

Osteoarthritis (OA) is a condition that commonly affects the elderly.[@b9-jomes-26-036] Although the pathophysiology of OA has not been clearly identified, the association between knee OA and obesity has been clearly identified well.[@b10-jomes-26-036],[@b11-jomes-26-036] In addition, weight-bearing joints such as the knee joints are reported to be at a greater risk of OA due to the biomechanical effects of surplus weight.[@b12-jomes-26-036] Lumbar spine OA (lumbar spondylosis \[LS\]) is also known to have various causes. As it is observed in the synovial joint, excess loads on joints is associated with degenerative changes, and osteophytosis and intervertebral disks.[@b13-jomes-26-036],[@b14-jomes-26-036]

The Korean society is rapidly aging. In 2010, Koreans aged ≥65 years made up 11.0% of the national population, and the figure is projected to increase to 24.3% by 2030 and to 37.4% by 2050.[@b15-jomes-26-036] On the other hand, obesity has also been on a continual increase due to reduction of physical activity caused by Koreans' westernized dietary habits and advances in transportation.[@b16-jomes-26-036] Aging-associated diseases are expected to put a huge socioeconomic burden on the Korean society, a fact that demands effective disease prevention and management strategies.

Of various aging-associated diseases, obesity, sarcopenia, and OA have been recognized as important health issues concerning the elderly population, as the conditions greatly impact the elderly's activities of daily life (ADL) and quality of life (QOL).[@b1-jomes-26-036],[@b5-jomes-26-036],[@b17-jomes-26-036] The present study analyzed data from the Korea National Health and Nutrition Examination Survey (KNHANES) to examine the associations between obesity, sarcopenia, and osteoarthritis in the elderly population (≥65 years). It was aimed at providing elementary data required for developing effective disease prevention and management programs for the elderly population in Korea.

METHODS
=======

Study subjects
--------------

The present study used the first- and second-year (2010--2011) data of the fifth Korea National Health and Nutrition Examination Survey (KNHANES V-1 and V-2). Approval for the study was obtained from the research ethics committee of the Korea Center for Disease Control and Prevention (IRB No. 2010-02CON-21-C, 2011-02CON-06-C).

Of 17,476 respondents, 8,958 participated in the first year (2010) and 8,518 participated in the second year (2011) of the fifth KNHANES. Of these respondents, 1,322 were men and 1,754 were women, aged ≥65 years. Of these men and women, 824 men and 1,071 women underwent dual-energy X-ray absorptiometry (DXA), of whom 818 men and 1,062 women underwent knee radiography. Six men and 7 women were excluded because of chronic renal failure, which left 812 men and 1,055 women for the knee OA analysis. Subsequently, 2 additional men were excluded because of incomplete or missing data, which resulted in 810 men and 1,055 women selected for the final subject pool.

On the other hand, 778 men and 1,004 women underwent a lumbar radiography, of whom 6 men and 5 women were excluded because of chronic renal failure. Thus, 772 men and 999 women were finally selected for the LS analysis. Subsequently, 2 additional men were excluded because of incomplete or missing data, which resulted in 770 men and 999 women selected for the study analysis.

The exclusion of men and women with chronic renal failure was based on a previous report that the condition is associated with sarcopenia.[@b18-jomes-26-036]

Study methods
-------------

Plain radiography was used for the assessment of knee OA (plain radiographs, SD3000 Synchro Stand, Accele Ray). The subjects were asked to stand with their bodyweights evenly distributed between two feet for anteroposterior imaging of the patella. The subjects were then asked to rotate at a 90° from the original standing position with the knee bent at about 30° for lateral measurement. For the lumbar measurement, the subjects were positioned to maintain lordosis posture, and then anteroposterior and lateral views of L3 throughL4 were obtained.

For measurement of total fat mass and skeletal muscle mass, DXA was performed (Hologic, Inc., Bedford, MA, USA). For measurement of appendicular skeletal muscle mass (ASM), the Heymsfield method[@b19-jomes-26-036] was used, which is the sum of fat-free soft tissue masses in the limbs.

Definitions and subject classifications
---------------------------------------

According to the World Health Organization (WHO) classification of body mass index (BMI) for Asians, obesity was defined as a BMI of ≥25 kg/m^2^.[@b20-jomes-26-036] The present study used DXA to measure muscle mass. Conforming to the results of a previous Korean study[@b8-jomes-26-036],[@b21-jomes-26-036], sarcopenia was diagnosed based on the value obtained by dividing the ASM by bodyweight (ASM/weight×100). To estimate the cutoff value for sarcopenia diagnosis, the mean ASM index (ASM/weight×100) of healthy young men and women aged 20--39 years and standard deviation (SD) were used. In selecting young sex-matched reference groups of healthy 20- to 39-year-olds, individuals who had diabetes, stroke, cardiovascular disease, thyroid disease, arthritis, tuberculosis, asthma, chronic obstructive pulmonary disease, hepatocirrhosis, renal disease, and cancer were excluded. Sarcopenia was determined when the measurement was 2SDs below the average of the young sex-matched reference group.[@b22-jomes-26-036],[@b23-jomes-26-036]

Sarcopenic obesity was determined if a subject had both sarcopenia and obesity. The severity of radiographic knee osteoarthritis was assessed with the Kellgren/Lawrence grading system as follows[@b24-jomes-26-036]: grade 0, normal; grade 1, slight osteophytic lipping; grade 2, definite osteophytes; grade 3, definite osteophytes and marked joint space narrowing; and grade 4, marked joint space narrowing and below-cartilage sclerosis. Knee OA was determined for the subjects with a KL grade of ≥2.

Owing to the absence of an international consensus on the diagnostic criteria for LS, published raw data were used and diagnostic criteria were developed based on Kellgren and Lawrence's criteria.[@b24-jomes-26-036] For the assessment, grade levels of 0--2 were established based on those developed by Yoshimura et al.[@b25-jomes-26-036] LS was diagnosed in the presence of at least one lumbar assessed as a KL grade of ≥2.

The subjects were divided into male and female groups, which were subsequently divided into four body composition groups according to the subjects' sarcopenia and obesity statuses, and sarcopenic obesity (SO) status as follows: normal body composition (NO), sarcopenic non-obesity (SP), non-SO (OB), and SO.

Statistical analysis
--------------------

One-way analysis of variance was used to process the subjects' demographic data. For post hoc analysis, the Bonferroni method was used, and continuous variables were presented as mean±SD.

To examine the correlations among obesity, sarcopenia, and OA, the sampling weight for each survey criterion recommended by the KNHANES and the number of respondents in each survey year were considered. Combined weights were calculated by multiplying the 2010 sampling unit ratio of 192:272 with the 2010 sampling weight and the 2011 sampling unit ratio of 80:272 with the 2011 sampling weight. By using the above-mentioned figures, a logistic regression based on a complex sampling design was performed.

Based on a previous study that found that age-and-waist circumference-based abdominal obesity was pathophysiologically and statistically associated with sarcopenia obesity[@b26-jomes-26-036], age and waist circumference were used as covariates to control the effects on the relationships among obesity, sarcopenia, and OA. Model 1 incorporated only age as a covariate, while model 2 incorporated both age and waist circumference as covariates. Continuous variables were expressed as mean±SD. Odds ratios and 95% confidence intervals (CIs) were calculated, and the statistical significance of group differences based on the reference groups was verified. Statistical significance was determined based on a *P* value of \<0.05. Statistical analysis was performed with SPSS version 22.0 (IBM, NY, USA).

RESULTS
=======

Characteristics of the subjects according to 4 body compositions
----------------------------------------------------------------

In general, the obesity groups showed a significantly greater body weight, waist circumference, BMI, and total body fat. On the other hand, the sarcopenia groups showed a significantly greater total body fat and significantly lower ASM and ASM index ([Tables 1](#t1-jomes-26-036){ref-type="table"} and [2](#t2-jomes-26-036){ref-type="table"}).

Correlation between knee OA and body compositions
-------------------------------------------------

Among the male subjects aged ≥65 years, the SO group had an unadjusted odds ratio (OR) of 1.88 (95% CI, 1.22--2.89) and an age-adjusted OR of 1.92 (95% CI, 1.23--2.99), indicating a significant increase. However, when adjusted for both age and waist circumference, no significant difference was found ([Table 3](#t3-jomes-26-036){ref-type="table"}).

Among the female subjects aged ≥65 years, the OB group had an unadjusted OR (95% CI) of 6.03 (1.90--19.15), an age-adjusted OR of 7.64 (2.37--24.57), and an age-and-waist circumference-adjusted OR of 5.88 (1.71--20.22), indicating a significant increase. The SO group had corresponding ORs (95% CI) of 1.97 (1.31--2.95), 2.43 (1.60--3.69), and 1.80 (1.03--3.12), which indicated a significant increase ([Table 3](#t3-jomes-26-036){ref-type="table"}).

Correlations between LS and body compositions
---------------------------------------------

No significant OR was found for body composition and LS among those aged ≥65 years in both sexes ([Table 4](#t4-jomes-26-036){ref-type="table"}).

DISCUSSION
==========

The present study examined the correlations among obesity, sarcopenia, and OA (knee OA, lumbar OA). The results indicated that in the male SO group aged ≥65 years, the risk of knee OA increased significantly both before and after adjusting for age. However, no significant difference was found when no adjustment was made for both age and waist circumference. In other words, waist circumference is a significant influencing factor of knee OA in elderly men.

In the female subjects aged ≥65 years, SO was found to significantly increase the risk of knee OA. In contrast to their male counterparts, the female subjects with SO had an increased risk of knee OA even after adjusting for both age and waist circumference. It is interesting that the female OB group had a significantly increased risk of knee OA both before and after adjusting for age, which suggests that obesity itself is highly correlated with knee OA in the elderly female group.

A previous Korean study[@b26-jomes-26-036] examined the association between SO and knee OA in individuals aged ≥50 years without discriminating for sex and found that the risk of knee OA increased in both the OB and SO groups when adjusted for age, sex, and waist circumference. However, the present study included sex-discriminated subjects aged ≥65 years, and the risk of knee OA increased significantly in the female SO group only, when both age and waist circumference were unadjusted for. In addition, only the OB group of female subjects was found to have a significantly increased risk of knee OA.

It is noteworthy that the female OB group in the present study had a greater OR than the women aged ≥65 years in the SO group. This may be attributed to the difference in obesity diagnosis criteria between the two studies, which was a BMI of 27.5 kg/m^2^ in the reference study and BMI of 25 kg/m^2^ in the present study.[@b20-jomes-26-036],[@b26-jomes-26-036],[@b27-jomes-26-036] In other words, owing to the increased prevalence of SO due to aging[@b22-jomes-26-036], the OB prevalence decreased and the SO prevalence increased in the female subjects aged ≥65 years. Therefore, the increased OR does not have significant implications.

The present study did not find a significant correlation between LS and the presence of either obesity or sarcopenia. Considering a previous research that found a positive correlation between obesity and age-associated LS[@b25-jomes-26-036],[@b28-jomes-26-036],[@b29-jomes-26-036], attempting to identify the correlation using ASM as the only criterion for sarcopenia proved hugely limiting. According to a previous study[@b30-jomes-26-036], aging-related changes in body composition vary according to body parts. Based on this finding, incorporating additional indexes that reflect muscle masses surrounding the spine and torso, in addition to the ASM, will help clarify the association with LS.

Recently, the European Working Group on Sarcopenia in Older People suggested an updated definition of sarcopenia and established reduced muscle strength (i.e., muscle strength or performance and functioning) as important diagnostic criteria for the condition, in addition to reduced muscle mass.[@b31-jomes-26-036] Moreover, based on a previous study that found no significant relationship between aging-associated reduction in muscle mass and strength, assessment of muscle quality, in addition to muscle mass, appears to be important in diagnosing sarcopenia. Future studies that incorporate these criteria will clarify the relationship between sarcopenia and OA.

Previous reports indicated that in addition to aging, various other factors such as physical activity, energy, and hormone can affect reduction in skeletal muscle mass and strength.[@b32-jomes-26-036],[@b33-jomes-26-036] Various adipokines, including leptin, adiponectin, resistin, and visfatin, have been reported to be secreted from fat tissues because of obesity, causing fat cells to infiltrate and inflame the muscles, which results in decreased muscle mass[@b34-jomes-26-036] and articular cartilage catabolism.[@b35-jomes-26-036] Based on this finding, approaching the subject from an endocrinal standpoint appears to be beneficial.

The present study has several limitations. First, skeletal muscle mass was measured with DXA, and the measured values tend to overestimate the total skeletal muscle mass.[@b36-jomes-26-036] As such, for a more accurate assessment of sarcopenia in the future, computed tomography or magnetic resonance imaging are required.[@b37-jomes-26-036] In future studies, in addition to plain radiography, clinical examinations, including physical examination and patient interview for medical history taking to collect information pertaining to knee pain, severity of pain, knee stiffness, and so on in the future studies are needed. Second, because of the nature of this cross-sectional study, identifying a causal relationship or predicting trends over time was difficult. Therefore, a prospective study consisting of a larger number of subjects will be beneficial. Third, because the present study only included data from the KNHANES for assessment of body compositions, the potential for selection bias exists. Finally, sex- and race-related differences in age-related physical composition changes have been reported.[@b30-jomes-26-036] As the present study was limited to examining Koreans aged ≥65 years, a follow-up study is needed to improve its external validity by comparing the results with those derived from other races.

In conclusion, although no association was found between LS and the presence of obesity or sarcopenia, the conditions were found to correlate with knee OA, which varied according to sex. In the male subjects, the SO group was 1.92 times more likely to develop knee OA than the reference group when age was unadjusted for. In the female subjects, the OB and SO groups were 5.88 and 1.80 times more likely to develop knee OA than the reference group when both age and waist circumference were unadjusted for. This sex-related difference suggests that in addition to the mechanical effects[@b12-jomes-26-036] of obesity and bodyweight on the risk of knee OA, sex-related difference in body composition may also have an effect.

Aging-related changes in physical composition, which vary according to sex, occur independent from changes in bodyweight.[@b30-jomes-26-036],[@b38-jomes-26-036] In addition, the obesity index, BMI (kg/m^2^), does not reflect body fat composition. Even at the same BMI, fat mass greater than skeletal muscle mass poses a greater risk of knee OA than obesity measured based on BMI because fat tissues are endocrinal organs that affect the pathophysiology of knee OA; thus, the endocrinal effect will be more significant.[@b34-jomes-26-036],[@b35-jomes-26-036],[@b39-jomes-26-036]

Abdominal fat, which accounts for a significant portion of total body fat, is closely related to waist circumference.[@b40-jomes-26-036] Therefore, the sex-related difference in knee OA is thought to b e attributable to the sex-related differences in body composition and waist circumference, with the latter accounting for a significant portion of the total body fat. However, the underlying mechanism of these differences has not been clarified yet. Therefore, to elucidate the mechanism of the sex-related differences in knee OA and body compositions, an integrated approach is needed through studies that examine the interplay between potential influencing factors.

Finally, obesity and sarcopenia assessment methods that are better suited for use in Korea, clearer diagnostic criteria, and early screening will be beneficial. On this note, preventive and treatment methods that incorporate exercise and diet are needed.
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###### 

Characteristics of the subjects with knee osteoarthritis according to body composition and sex

                     Male[\*](#tfn2-jomes-26-036){ref-type="table-fn"}   Female[\*](#tfn2-jomes-26-036){ref-type="table-fn"}                                                                                                                                    
  ------------------ --------------------------------------------------- ----------------------------------------------------- ----------- ----------- ----------- --------- ---------------- ------- ----------- ----------- ----------- ----------- --------- ----------------
  Age (year)         810                                                 71.5±4.9                                              72.6±5.3    69.6±3.7    71.2±4.2    0.03      SP\>NO, OB, SO   1,055   74±6.0      72.7±5.6    72.7±5.4    71.5±4.9    \<0.001   NO, OB\>SP, SO
                                                                                                                                                                                                                                                                
  Height (cm)        810                                                 165.2±5.3                                             165.3±5.8   166.1±5.1   165.4±5.5   0.504                      1,055   150.2±6.0   150.9±5.4   151.9±6.5   151.1±5.4   0.036     
                                                                                                                                                                                                                                                                
  Weight (kg)        810                                                 57.1±7.3                                              61.5±6.2    73.1±5.9    73.3±6.2    \<0.001   SO, OB\>SP\>NO   1,055   47.9±6.5    52.2±5.2    61±6.0      63.6±7.4    \<0.001   SO, OB\>SP\>NO
                                                                                                                                                                                                                                                                
  WC (cm)            804                                                 78±7.5                                                84.1±6.1    90.7±4.8    93.9±5.8    \<0.001   SO, OB\>SP\>NO   1,047   75.6±7.4    81±6.0      89.7±5.2    91.7±7.1    \<0.001   SO, OB\>SP\>NO
                                                                                                                                                                                                                                                                
  BMI (kg/m^2^)      810                                                 20.9±2.2                                              22.5±1.7    26.5±1.0    26.8±1.4    \<0.001   SO, OB\>SP\>NO   1,055   21.2±2.1    22.9±1.6    26.4±1.2    27.8±2.5    \<0.001   SO\>OB\>SP\>NO
                                                                                                                                                                                                                                                                
  WB fat mass (kg)   810                                                 9.8±2.8                                               15.1±3.2    15.4±1.9    20.2±3.6    \<0.001   SO\>OB, SP\>NO   1,055   13.5±3.5    18.9±3.1    19.7±2.6    25±4.4      \<0.001   SO\>OB, SP\>NO
                                                                                                                                                                                                                                                                
  WB fat (%)         810                                                 17.1±3.4                                              24.6±3.9    21.2±2.1    27.7±3.8    \<0.001   SO\>SP\>OB\>NO   1,055   28±4.8      36.2±3.7    32.4±2.2    39.5±3.7    \<0.001   SO\>SP\>OB\>NO
                                                                                                                                                                                                                                                                
  ASM (kg)           810                                                 19.6±2.0                                              18.4±2.0    24.6±2.2    21.2±2.3    \<0.001   OB\>SO\>NO\>SP   1,055   13.3±1.6    12.2±1.4    16.2±1.6    14.2±1.9    \<0.001   OB\>SO\>NO\>SP
                                                                                                                                                                                                                                                                
  SMI (%)            810                                                 34.5±1.6                                              30±1.8      33.7±1.1    28.9±2.1    \<0.001   NO, OB\>SP\>SO   1,055   28±2.0      23.4±1.6    26.6±0.8    22.4±1.8    \<0.001   NO\>OB\>SP\>SO

Values are presented as mean±standard deviation (SD).

The numbers of participants in all the body composition categories (normal body composition \[NO\], sarcopenic non-obesity \[SP\], non-sarcopenic obesity \[OB\], and sarcopenic obesity \[SO\]) were as follows: among the male subjects, n = 207, 387, 28, and 188, respectively, and among the female subjects, n = 307, 359, 35, and 354, respectively.

WC, waist circumference; BMI, body mass index; WB, whole-body; ASM, appendicular skeletal muscle mass; SMI, skeletal muscle mass index.

###### 

Characteristics of the subjects with lumbar spondylosis according to body composition and sex

                     Male[\*](#tfn5-jomes-26-036){ref-type="table-fn"}   Female[\*](#tfn5-jomes-26-036){ref-type="table-fn"}                                                                                                                                  
  ------------------ --------------------------------------------------- ----------------------------------------------------- ----------- ----------- ----------- --------- ---------------- ----- ----------- ----------- ----------- ----------- --------- ----------------
  Age (year)         770                                                 71.5±5.0                                              72.5±5.4    69.6±3.7    71.1±4.2    0.034     SP, NO\>SO, OB   999   73.8±6.1    72.6±5.5    72.4±5.1    71.5±4.9    \<0.001   NO\>SP, OB, SO
                                                                                                                                                                                                                                                              
  Height (cm)        770                                                 165.1±5.4                                             165.4±5.8   166.1±5.1   165.3±5.6   0.519                      999   150.3±6.1   151.0±5.4   152.2±6.7   151.1±5.4   0.045     
                                                                                                                                                                                                                                                              
  Weight (kg)        770                                                 57.2±7.2                                              61.7±6.3    73.1±5.9    73.1±6.0    \<0.001   SO, OB\>SP\>NO   999   48.0±6.6    52.3±5.2    61.1±6.1    63.6±7.4    \<0.001   SO, OB\>SP\>NO
                                                                                                                                                                                                                                                              
  WC (cm)            764                                                 78.2±7.3                                              84.3±6.1    90.7±4.8    93.7±5.7    \<0.001   SO, OB\>SP\>NO   992   75.8±7.4    81.2±5.9    89.7±5.1    91.8±7.2    \<0.001   SO, OB\>SP\>NO
                                                                                                                                                                                                                                                              
  BMI (kg/m^2^)      770                                                 20.9±2.1                                              22.5±1.7    26.5±1.0    26.7±1.4    \<0.001   SO, OB\>SP\>NO   999   21.2±2.1    22.9±1.5    26.3±1.2    27.8±2.5    \<0.001   SO\>OB\>SP\>NO
                                                                                                                                                                                                                                                              
  WB fat mass (kg)   770                                                 9.9±2.8                                               15.2±3.2    15.4±1.9    20.1±3.5    \<0.001   SO\>OB, SP\>NO   999   13.6±3.6    18.9±3.1    19.6±2.7    25±4.4      \<0.001   SO\>OB, SP\>NO
                                                                                                                                                                                                                                                              
  WB fat (%)         770                                                 17.2±3.4                                              24.7±3.9    21.2±2.1    27.7±3.7    \<0.001   SO\>OB\>SP\>NO   999   28.0±4.7    36.3±3.7    32.2±2.2    39.4±3.6    \<0.001   SO\>SP\>OB\>NO
                                                                                                                                                                                                                                                              
  ASM (kg)           770                                                 19.7±2.4                                              18.5±2.1    24.6±2.2    21.2±2.3    \<0.001   OB\>SO\>NO\>SP   999   13.4±1.7    12.2±1.4    16.2±1.6    14.2±1.9    \<0.001   OB\>SO\>NO\>SP
                                                                                                                                                                                                                                                              
  SMI (%)            770                                                 34.5±1.6                                              30±1.8      33.7±1.1    29±2.0      \<0.001   NO, OB\>SP\>SO   999   27.9±2.0    23.4±1.6    26.5±0.8    22.4±1.8    \<0.001   NO\>OB\>SP\>SO

Values are presented as mean ± standard deviation (SD).

The numbers of participants in all the body composition categories (normal body composition \[NO\], sarcopenic non-obesity \[SP\], non-sarcopenic obesity \[OB\], and sarcopenic obesity \[SO\]) were as follows: among the male subjects, n = 201, 363, 28, and 178, respectively, and among the female subjects, n = 286, 338, 32, and 343, respectively.

WC, waist circumference; BMI, body mass index; WB, Whole-body; ASM, appendicular skeletal muscle mass; SMI, skeletal muscle mass index.

###### 

Association between radiographic knee osteoarthritis and the 4 body composition categories

  Sex      Group   Crude        Model 1              Model 2                                                                                 
  -------- ------- ------------ -------------------- --------- ------------ -------------------- --------- ------------ -------------------- --------
  Male     NO      207 (28.0)   Reference                      207 (28.0)   Reference                      205 (28.1)   Reference            
           SP      387 (45.6)   1.23 (0.85--1.79)    0.279     387 (45.6)   1.14 (0.79--1.65)    0.476     383 (45.4)   1.00 (0.66--1.53)    0.989
           OB      28 (3.2)     1.41 (0.52--3.81)    0.502     28 (3.2)     1.54 (0.55--4.33)    0.411     28 (3.3)     1.13 (0.37--3.43)    0.832
           SO      188 (23.2)   1.88 (1.22--2.89)    \<0.05    188 (23.2)   1.92 (1.23--2.99)    \<0.005   188 (23.3)   1.34 (0.70--2.55)    0.379
           Total   810                                         810                                         804                               
                                                                                                                                             
  Female   NO      307 (30.1)   Reference                      307 (30.1)   Reference                      304 (30.1)   Reference            
           SP      359 (33.5)   1.01 (0.69--1.48)    0.964     359 (33.5)   1.11 (0.76--1.63)    0.581     356 (33.5)   0.99 (0.66--1.49)    0.97
           OB      35 (3.1)     6.03 (1.90--19.15)   \<0.005   35 (3.1)     7.64 (2.37--24.57)   \<0.005   35 (3.1)     5.88 (1.71--20.22)   \<0.05
           SO      354 (33.3)   1.97 (1.31--2.95)    \<0.005   354 (33.3)   2.43 (1.60--3.69)    \<0.001   352 (33.3)   1.80 (1.03--3.12)    \<0.05
           Total   1,055                                       1,055                                       1,047                             

Crude and odds ratios (ORs), and 95% confidence intervals (95% CI) were calculated by using the complex-sample logistic regression analysis.

Model 1 was adjusted for age.

Model 2 was adjusted for age and waist circumference.

NO, normal body composition; SP, sarcopenic non-obesity; OB, non-sarcopenic obesity; SO, sarcopenic obesity.

###### 

Association between radiographic lumbar spondylosis and the 4 body composition categories

  Sex      Group   Crude        Model 1             Model 2                                                                             
  -------- ------- ------------ ------------------- --------- ------------ ------------------- ------- ------------ ------------------- -------
  Male     NO      201 (30.2)   Reference                     201 (30.2)   Reference                   199 (30.3)   Reference           
           SP      363 (35.8)   0.88 (0.57--1.34)   0.54      363 (35.8)   0.79 (0.52--1.20)   0.266   359 (35.8)   0.79 (0.50--1.24)   0.306
           OB      28 (6.8)     1.50 (0.63--3.59)   0.364     28 (6.8)     1.69 (0.69--4.14)   0.253   28 (6.9)     1.66 (0.61--4.47)   0.319
           SO      178 (27.1)   0.89 (0.58--1.38)   0.607     178 (27.1)   0.91 (0.59--1.38)   0.641   178 (27.0)   0.89 (0.50--1.57)   0.681
           Total   770                                        770                                      764                              
                                                                                                                                        
  Female   NO      286 (30.2)   Reference                     286 (30.2)   Reference                   283 (30.2)   Reference           
           SP      338 (33.1)   1.05 (0.71--1.54)   0.813     338 (33.1)   1.14 (0.78--1.68)   0.493   335 (33.1)   0.99 (0.67--1.47)   0.955
           OB      32 (3.0)     1.75 (0.65--4.69)   0.266     32 (3.0)     2.23 (0.82--6.07)   0.117   32 (3.1)     1.56 (0.54--4.50)   0.407
           SO      343 (33.7)   0.91 (0.62--1.35)   0.643     343 (33.7)   1.09 (0.71--1.66)   0.692   342 (33.7)   0.72 (0.41--1.24)   0.235
           Total   999                                        999                                      992                              

Crude and each odds ratios (ORs), and 95% confidence intervals (95% CI) calculated by using the complex-sample logistic regression analysis.

Model 1 was adjusted for age.

Model 2 was adjusted for age and waist circumference.

NO, normal body composition; SP, sarcopenic non-obesity; OB, non-sarcopenic obesity; SO, sarcopenic obesity.
